Literature DB >> 8581267

The antinociceptive effect of 1-(2-trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse.

R L Handy1, P Wallace, Z A Gaffen, K J Whitehead, P K Moore.   

Abstract

1-(2-trifluoromethylphenyl)imidazole (TRIM) is a potent inhibitor of neuronal (mouse cerebellar) and inducible (lung from endotoxin-pretreated rats) isoforms of nitric oxide synthase (NOS) with IC50 values of 28.2 microM and 27.0 microM, respectively. In contrast, TRIM is a poor inhibitor of bovine aortic endothelial NOS with an IC50 of 1057.5 microM. TRIM (10-50 mg kg-1) administered i.p. exhibits dose-related antinociceptive activity in the mouse (assessed as inhibition of late phase formalin-induced hindpaw licking behaviour) with an ED50 of 85.8 mumol kg-1. In contrast, TRIM (50 mg kg-1, i.p.) failed to influence mean arterial blood pressure in the urethane-anaesthetized mouse. Thus, TRIM may be of use as an experimental tool with which to investigate the biological roles of nitric oxide (NO) within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581267      PMCID: PMC1909047          DOI: 10.1111/j.1476-5381.1995.tb15078.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  7 in total

Review 1.  Inhibition of nitric oxide synthase--potential for a novel class of therapeutic agent?

Authors:  J E Ogden; P K Moore
Journal:  Trends Biotechnol       Date:  1995-02       Impact factor: 19.536

2.  7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure.

Authors:  P K Moore; R C Babbedge; P Wallace; Z A Gaffen; S L Hart
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

3.  Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole and phenylimidazoles.

Authors:  D J Wolff; G A Datto; R A Samatovicz; R A Tempsick
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

4.  Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles.

Authors:  R C Babbedge; P A Bland-Ward; S L Hart; P K Moore
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.

Authors:  G A Joly; K Narayanan; O W Griffith; R G Kilbourn
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

6.  Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline.

Authors:  E S Furfine; M F Harmon; J E Paith; R G Knowles; M Salter; R J Kiff; C Duffy; R Hazelwood; J A Oplinger; E P Garvey
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

7.  Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas.

Authors:  E P Garvey; J A Oplinger; G J Tanoury; P A Sherman; M Fowler; S Marshall; M F Harmon; J E Paith; E S Furfine
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

  7 in total
  12 in total

1.  Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance.

Authors:  Y A Kolesnikov; Y X Pan; A M Babey; S Jain; R Wilson; G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Coactivation of NMDA receptors by glutamate and D-serine induces dilation of isolated middle cerebral arteries.

Authors:  Jillian L LeMaistre; Samuel A Sanders; Michael J Stobart; Lingling Lu; J David Knox; Hope D Anderson; Christopher M Anderson
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-09       Impact factor: 6.200

3.  Nitric oxide synthase in cardiac sarcoplasmic reticulum.

Authors:  K Y Xu; D L Huso; T M Dawson; D S Bredt; L C Becker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

4.  Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.

Authors:  R L Handy; H L Harb; P Wallace; Z Gaffen; K J Whitehead; P K Moore
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

5.  Selective inhibition of thapsigargin-induced contraction and capacitative calcium entry in mouse anococcygeus by trifluoromethylphenylimidazole (TRIM).

Authors:  A Gibson; F Fernandes; P Wallace; I McFadzean
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

6.  Store-operated Ca2+ entry in sensory neurons: functional role and the effect of painful nerve injury.

Authors:  Geza Gemes; Madhavi Latha Yadav Bangaru; Hsiang-En Wu; Qingbo Tang; Dorothee Weihrauch; Andrew S Koopmeiners; James M Cruikshank; Wai-Meng Kwok; Quinn H Hogan
Journal:  J Neurosci       Date:  2011-03-09       Impact factor: 6.167

7.  Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils.

Authors:  R C Zanardo; E Costa; H H Ferreira; E Antunes; A R Martins; F Murad; G De Nucci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

8.  Effects of nitric oxide synthase inhibition in the dorsolateral periaqueductal gray matter on ethanol withdrawal-induced anxiety-like behavior in rats.

Authors:  Vivian Taciany Bonassoli; Ewandro Braz Contardi; Humberto Milani; Rúbia Maria Weffort de Oliveira
Journal:  Psychopharmacology (Berl)       Date:  2013-03-15       Impact factor: 4.530

9.  Role of GABA receptors in nitric oxide inhibition of dorsolateral periaqueductal gray neurons.

Authors:  Jihong Xing; De-Pei Li; Jianhua Li
Journal:  Neuropharmacology       Date:  2008-01-28       Impact factor: 5.250

10.  On the selectivity of neuronal NOS inhibitors.

Authors:  B Pigott; K Bartus; J Garthwaite
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.